<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib137">
 <element-citation publication-type="journal" id="sref137">
  <person-group person-group-type="author">
   <name>
    <surname>Sun</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>Q.</given-names>
   </name>
   <name>
    <surname>Hou</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Sun</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Tang</surname>
    <given-names>Q.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Wu</surname>
    <given-names>S.</given-names>
   </name>
  </person-group>
  <article-title>Kaempferol-3-
   <italic>O</italic>-glucorhamnoside inhibits inflammatory responses via MAPK and NF-ÎºB pathways 
   <italic>in vitro</italic> and 
   <italic>in vivo</italic>
  </article-title>
  <source>Toxicol. Appl. Pharmacol.</source>
  <volume>364</volume>
  <year>2019</year>
  <fpage>22</fpage>
  <lpage>28</lpage>
  <ext-link ext-link-type="uri" xlink:href="https://doi:10.1016/j.%20taap.2018.12.008" id="intref0605" xmlns:xlink="http://www.w3.org/1999/xlink">https://doi:10.1016/j. taap.2018.12.008</ext-link>
  <pub-id pub-id-type="pmid">30528763</pub-id>
 </element-citation>
</ref>
